Associate Professor and Honorary Consultant in Diabetes and Endo. Interested in obesity, bariatric surgery and diabetes. ASO trustee and ABCD academic committee
Leicester, England
Joined September 2012
- Tweets3K
- Following709
- Followers684
- Likes5K
Dimitris Papamargaritis retweeted
INSTEAD OF WATCHING AN HOUR OF NETFLIX TONIGHT.
This 60-minute Cambridge lecture by Demis Hassabis will teach you more about the future of AI than most people will learn in the next 5 years.
Bookmark it and give it an hour, no matter what.
Dimitris Papamargaritis retweeted
New from Professor Blau, inhibition of the gerozyme 15-PGDH inhibition promotes muscle repair and strength recovery during GLP-1 receptor agonist-induced weight loss pnas.org/doi/10.1073/pnas.26…
Dimitris Papamargaritis retweeted
Happy to share our latest manuscript: The Effect of Acute Aerobic Exercise on the Time Spent in Hypoglycaemia After Bariatric Surgery (The BariEX Study)
@ri_tis @DrLouisaHerring @JournalObesity
link.springer.com/article/10…
Dimitris Papamargaritis retweeted
New @Nature
A quintuple [GLP-1 + 4 other] receptor agonist drug that exceeds effects of the dual receptor (GLP-1 and GIP, tirzepatide) in the experimental model vs diabetes and obesity
(in case you thought a dual receptor was max effect, as also seen with retatrutide, a triple receptor agonist)
nature.com/articles/s41586-0…
Dimitris Papamargaritis retweeted
Here the authors propose prioritization of individuals with #obesity and a high risk for obesity associated complications for weight loss interventions nature.com/articles/s41591-0…
Dimitris Papamargaritis retweeted
After an extraordinary 80 yrs of combined #NHS service, we prepare to say farewell to two cherished members of our team, Carolyn Currie & Penny Donley, who will be retiring at the end of March 2026.
🔗Read the full article: leicesterdiabetescentre.org.…
ALT (L-R) Carolyn Currie and Penny Donley
Dimitris Papamargaritis retweeted
It turns out that weight regain reverts many of the benefits achieved with #weightloss Insights from the CALERIE-2 trial
diabetesjournals.org/care/ar…
Dimitris Papamargaritis retweeted
Oral GLP-1. Once daily. 16.3% placebo-adjusted weight loss at 44 weeks.
No plateau at 56.
2% discontinuation rate with 2.5mg start.
Aleniglipron just reset expectations for what a pill can do.
Phase 3 starts 2H 2026. 👀
Press Release: ir.structuretx.com/news-rele…
$GPCR #ObesityMedicine #GLP1
Dimitris Papamargaritis retweeted
«Θα ήταν ηλίθιο αν το μπάσκετ δεν ήταν καλύτερο σήμερα απ'ότι ήταν πριν 20-30 χρόνια και αντίστοιχα σε 20-30 χρόνια θα είναι καλύτερο από ότι είναι τώρα».
Φανταστικό πεντάλεπτο λουτρό αλήθειας και σοφίας από τον καλύτερο παίκτη στον κόσμο.
Dimitris Papamargaritis retweeted
❗️Results from SURPASS-EARLY ❗️by @SDelprato @ATTDconf #ATTD2026
Tirzepatide use in early after T2D diagnosis vs conventional care - 2 year results
🔸⬇️Hba1c
🔹⬇️weight
🔸⬇️Cv risk markers (lipid profile/BP)
🔹Effect on beta cell/c-peptide/insulin levels based on OGTT
Essentially…. Tirzepatide does what it is expected to do in T2DM 🤷♂️😇
@drpatrickholmes @AmarPut @kamleshkhunti @DLBHATTMD @pabeda1 @AskDrShashank
Dimitris Papamargaritis retweeted
Today is #WorldObesityDay!
#Obesity is a common condition but is often misunderstood & under-treated.
We have opportunities for people to join #research into potential new treatments.
Join our registry to receive opportunities by email: forms.office.com/pages/respo…
@ObesityDayEU
Dimitris Papamargaritis retweeted
The BELIEVE study, the efficacy and safety of intravenous bimagrumab and open-label subcutaneous semaglutide, alone or in combination, in adults with #obesity nature.com/articles/s41591-0…
Dimitris Papamargaritis retweeted
GIP/GLP-1 dual incretin receptor agonist #VK2735: Phase 2, 13-Week VENTURE Study. 14.7% weight loss with no indication of a plateau at Week 13. @AlkhouriNaim
onlinelibrary.wiley.com/doi/…
Dimitris Papamargaritis retweeted
It's a huge honour to have been chosen to give the Harry Keen Rank nutrition lecture. Thanks very much @DUK_research for your commitment to my work and to the many people who support @DiabetesUK- working together to improve care for people with diabetes in UK & internationally.
We’re excited that Professor @ClaireMeek5 will deliver the Harry Keen Rank Nutrition Lecture at #DUKPC26.
She’ll share insights from her research on the nutritional management of diabetes in pregnancy, work we’ve supported over many years.
Join us there!
dukpc.diabetes.org.uk/ticket…
Dimitris Papamargaritis retweeted
The Effect of Increased Sodium Intake with a Carbohydrate-Rich Meal on Glucose Homeostasis in People without Diabetes after Roux-en-Y Gastric Bypass
@JournalObesity @SpringerNature @ri_tis @LDC_tweets
#ISRCTN: isrctn.com/ISRCTN12008159
link.springer.com/article/10…
Dimitris Papamargaritis retweeted
Looking forward to @ABCDiab Update 2026 with an amazing line up of speakers and all attending.
Best place to get updated with all things diabetes and for colleagues in training grades an opportunity to learn & network.
@youngdiabendo
@ketandhatariya
@ri_tis
@drpratikc
🚨 DU2026 is fully booked! 🚨
If you missed out on a place you can register to be added to a waiting list here abcd.care/civicrm/event/regi…
You will be notified if spaces become available.
Dimitris Papamargaritis retweeted
⚠️ Day 6 of #ARCEMRewind2025
⏪ Rewinding to June: Experts urged caution on overemphasising type 2 diabetes remission.
🔗 Read here: tinyurl.com/4e6b2a6t
@kamleshkhunti @LDC_tweets @ri_tis
Dimitris Papamargaritis retweeted
Do you have #Type2Diabetes & aged between 18-45 years?
The DANA #research study tests a digital programme specifically designed for people with type 2 diabetes, which aims to improve people’s health & wellbeing.
Find out more: dana-mydesmond.squarespace.c…
#BePartofResearch #health
Dimitris Papamargaritis retweeted
Don’t miss our biggest Diabetes Update yet—three days of education, discussion, and practical learning.
Taking place on the 28th - 30th January 2026 at Telford International Centre.
Secure your place - member rates available ow.ly/iVws50XsM0g
Dimitris Papamargaritis retweeted
@youngdiabendo the best place to prep for SCE and for trainees to meet UK experts in all aspects of diabetes @ABCDiab @DTN_UK @DSNforumUK
Don’t miss our biggest Diabetes Update yet—three days of education, discussion, and practical learning.
Taking place on the 28th - 30th January 2026 at Telford International Centre.
Secure your place - member rates available ow.ly/iVws50XsM0g